Kettle et al. compared two different siRNA molecules targeting MTH1, one of which, termed “oligo #3,” had been used to demonstrate that genetic ablation of MTH1 leads to reduced tumor growth in a previous study8, and found that only oligo #3 suppressed cancer cell survival, although both siRNAs caused significant MTH1 knockdown39. The gene discussed is NUDT1; the disease is cancer.